InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,283.55
(
0.80%
)
Post# of 251798
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119615
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 215752

Thursday, 02/15/2018 3:43:54 PM

Thursday, February 15, 2018 3:43:54 PM

Post# of 251798
(RVNC)—4Q17 Dysport sales reported by Ipsen +22.5% YoY:

https://www.businesswire.com/news/home/20180214006400/en

Ipsen’s reported 4Q17 Dysport sales of €87.2M include therapeutic indications in all geographies and cosmetic indications in the US/Canada. Outside the US/Canada, Ipsen receives royalty income on Dysport cosmetic sales by Nestlé.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up